Page URL:

UK initiative to sequence coronavirus patient genomes

18 May 2020
Appeared in BioNews 1047

Thirty-five thousand people in the UK with COVID-19 will have their genetic code analysed to understand how a person's genes affect how they react to the virus.

The study will look at the whole genomes of people with COVID-19 alongside medical information about peoples' symptoms, to explore whether specific genes cause some people to have a more severe reaction to the disease. This could help work out which existing treatments are most likely to be effective and speed up the development of new therapies.

Chief investigator Dr Kenneth Baillie, a consultant in critical care medicine from the University of Edinburgh said, 'Our genes play a role in determining who becomes desperately sick with infections like COVID-19. Understanding these genes will help us to choose treatments for clinical trials.'

Dr Bailllie's GenOMICC (Genetics of Susceptibility and Mortality in Critical Care) consortium will lead the enrolment for the new initiative. GenOMICC was set up in 2016 to sequence the genomes of people in intensive care as a result of infections to help understand how genetics affects disease severity. The team are already working with NHS hospitals across the UK.

The new initiative will involve 20,000 people of all ages currently or previously in intensive care with coronavirus – participation is voluntary but ideally they would like to recruit every COVID-19 patient receiving critical care. Fifteen thousand people who have mild or moderate symptoms will also be recruited.  

DNA samples from almost 2000 patients have already been collected and are being sequenced in the same Illumina laboratories where the sequencing for the 100,000 Genomics Project was carried out. Genomics England (who were responsible for the 100,000 genomes project), UK Research and Innovation, the Department of Health and Social Care and the National Institute for Health Research are all collaborating on the project.

The project will run in parallel with another study in which scientists are reading the genetic code of SARS-CoV-2, the virus which causes COVID-19 (see BioNews 1041).

Coronavirus patient DNA study could tell us why some fare worse
The Guardian |  13 May 2020
Coronavirus: Thousands of COVID-19 patients to have genome studied
BBC Scotland |  13 May 2020
New partnership to sequence human genomes in fight against coronavirus
Department of Health and Social Care |  13 May 2020
New partnership to sequence human genomes in the fight against COVID-19
National Institute for Health Research |  13 May 2020
UK initiative aims to sequence 35,000 COVID-19 patient genomes; link genetic makeup with disease severity
Genetic Engineering and Biotechnology News |  14 May 2020
5 July 2021 - by BioNews 
A conversation between Sarah Norcross (director of the Progress Educational Trust) and Professor Sir Mark Caulfield (outgoing chief scientist at Genomics England) about the past, present and future of NHS genomics...
24 May 2021 - by Jen Willows 
The Millennium Technology Prize has been awarded to UK researchers who developed a widely used approach to genome sequencing...
5 October 2020 - by Dr Laura Riggall 
The UK Government has launched a new strategy to establish the most advanced genomic healthcare system in the world in a bid to secure the UK as a global leader in genomics..
22 June 2020 - by Dr Laura Riggall 
Results from direct-to-consumer DNA testing kits could help identify genes that influence the way COVID-19 affects different people...
15 June 2020 - by Dr Molly Godfrey 
An association between patient blood type and severity of COVID-19 symptoms has been detected in preliminary studies...
4 May 2020 - by Dr Molly Godfrey 
Testing for coronavirus in Iceland has revealed that the virus may have been more widespread in the UK in February and early March than was previously thought...
30 March 2020 - by Alegria Vaz Mouyal 
The UK Government and its chief scientific adviser, Sir Patrick Vallance, have backed research to map how COVID-19 spreads and behaves by using whole genome sequencing...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.